Administration of oxathridine, a first‐in‐class histamine‐3 receptor partial agonist in healthy male volunteers: Central nervous system depression and pseudo‐hallucinations.

MLA

Dijkstra, Francis M., et al. “Administration of Oxathridine, a First‐in‐class Histamine‐3 Receptor Partial Agonist in Healthy Male Volunteers: Central Nervous System Depression and Pseudo‐hallucinations.” British Journal of Clinical Pharmacology, vol. 90, no. 1, Jan. 2024, pp. 321–35. EBSCOhost, https://doi.org/10.1111/bcp.15910.

APA

Dijkstra, F. M., Zuiker, R. G. J. A., Heuberger, J. A. A. C., Kanhai, K. M. S., De Kam, M., Duvauchelle, T., Lecomte, J., Labeeuw, O., Landais, L., Ligneau, X., Robert, P., Capet, M., Schwartz, J., & van Gerven, J. M. A. (2024). Administration of oxathridine, a first‐in‐class histamine‐3 receptor partial agonist in healthy male volunteers: Central nervous system depression and pseudo‐hallucinations. British Journal of Clinical Pharmacology, 90(1), 321–335. https://doi.org/10.1111/bcp.15910

Chicago

Dijkstra, Francis M., Rob G. J. A. Zuiker, Jules A. A. C. Heuberger, Kawita M. S. Kanhai, Marieke De Kam, Thierry Duvauchelle, Jeanne‐Marie Lecomte, et al. 2024. “Administration of Oxathridine, a First‐in‐class Histamine‐3 Receptor Partial Agonist in Healthy Male Volunteers: Central Nervous System Depression and Pseudo‐hallucinations.” British Journal of Clinical Pharmacology 90 (1): 321–35. doi:10.1111/bcp.15910.